Results 31 to 40 of about 83,877 (250)

Serum levels of matrix metalloproteinases-2 and-9 and their tissue inhibitors in inflammatory neuromuscular disorders [PDF]

, 2006
We monitored serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) before and during intravenously applied immunoglobulin (IVIG) therapy in 33 patients with chronic immune-mediated neuropathies and myopathies and 15 ...
B.G.H. Schoser, Carmeli E, Choi YC, D. Pongratz, Demestre M, Hartung HP, Kieseier BC, Kugler A, Lee MA, Mirowska D, S. Hurnaus, Schoser BGH, Shapiro S, Sharshar T, W. Mueller-Felber, Wiles CM   +15 more
core   +1 more source

Effect of IgG dimer concentration on the binding ability of IgG Fc fragment in IVIG to THP-1 cell surface receptors

Zhongguo shuxue zazhi, 2023
Objective To investigate the effect of immunoglobulin G (IgG) dimer concentration of intravenous immunoglobulin (IVIG) on the binding ability of IgG Fc fragment to THP-1 cell surface receptors.
Tingting LEI, Wei ZHANG, Changqing LI, Shengliang YE, Xi DU, Li MA   +5 more
doaj   +1 more source

Treatment for inclusion body myositis [PDF]

, 2015
Background Inclusion body myositis (IBM) is a late-onset inflammatory muscle disease (myopathy) associated with progressive proximal and distal limb muscle atrophy and weakness.
Brassington, Ruth, Dalakas, Marinos, Griggs, Robert, Jones, Katherine, Leong, Kevin, Miller, James, Rose, Michael R., Walter, Maggie C.   +7 more
core   +2 more sources

Intravenous Immunoglobulin Therapy in COVID-19 Disease

Sakarya Tıp Dergisi, 2021
High dose IVIG has been an appropriate immunomodulatory treatment option for prophylaxis of severe infections in autoimmune and inflammatory diseases [1].
Öner Özdemir, Ayşegül Pala, Elif Şeker   +2 more
doaj   +1 more source

Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study [PDF]

, 2019
We assessed the health-related quality of life (HRQoL) in CVID adults receiving different schedules of immunoglobulin replacement therapy (IgRT) by intravenous (IVIG), subcutaneous (SCIG), and facilitated (fSCIG) preparations.
Agostini, Carlo, Bonanni, Livia, Carrabba, Maria, Cinetto, Francesco, Crescenzi, Ludovica, Fabio, Giovanna, Farrugia, Albert, Milito, Cinzia, Neri, Raffaella, Pecoraro, Antonio, Pulvirenti, Federica, Quinti, Isabella, Spadaro, Giuseppe, Tabolli, Stefano   +13 more
core   +2 more sources

IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia

American Journal of Perinatology Reports, 2017
Background Treatment for neonatal alloimmune thrombocytopenia (NAIT) primarily involves maternal administration of intravenous immunoglobulin (IVIG) therapy and prednisone according to protocols based on risk stratification.
Alyssa Herrmann, Benjamin J. Samelson-Jones, Sami Brake, Renee Samelson   +3 more
doaj   +1 more source

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages

Human Vaccines & Immunotherapeutics, 2020
Intravenous immunoglobulin (IVIG) is one of the widely used immunotherapeutic molecules in the therapy of autoimmune and inflammatory diseases. Previous reports demonstrate that one of the anti-inflammatory actions of IVIG implicates suppression of ...
Chaitrali Saha, Prathap Kothapalli, Veerupaxagouda Patil, Gundallahalli Bayyappa ManjunathaReddy, Srini V Kaveri, Jagadeesh Bayry   +5 more
doaj   +1 more source

Impact of the COVID-19 pandemic on the frequency, clinical spectrum and outcomes of pediatric guillain-Barré syndrome in India: A multicentric ambispective cohort study

Annals of Indian Academy of Neurology, 2022
Objective: To study impact of COVID-19 pandemic on frequency, clinical/electrophysiological profile and treatment outcomes in pediatric Guillain-Barré syndrome (GBS). Background: GBS is the most frequent cause of pediatric acute flaccid paralysis.
Divyani Garg, Rajinder K Dhamija, Aditya Choudhary, Ritu Shree, Sujit Kumar, Priyanka Samal, Abhishek Pathak, Pamidimukkala Vijaya, Yareeda Sireesha, Sruthi S Nair, Sanjay Sharma, Soaham Desai, Human P Sinha, Ayush Agarwal, Ashish Upadhyay, M V Padma Srivastava, Rohit Bhatia, Awadh K Pandit, Rajesh K Singh, Alisha Reyaz, P M Yogeesh, Manish Salunkhe, Vivek Lal, Manish Modi, Gagandeep Singh, Monika Singla, Samhita Panda, Maya Gopalakrishnan, Inder Puri, Sudhir Sharma, Bismay Kumar, Prashant K Kushwaha, Harshadkumar Chovatiya, Teresa Ferreira, Sanjeev K Bhoi, Manish Bhartiya, Subhash Kaul, Anuja Patil, Neeharika L Mathukumalli, Madhu Nagappa, P Praveen Sharma, Aneesh Basheer, Dileep Ramachandran, Neetha Balaram, Jospeh Sebastian, Venugopalan Y Vishnu, on behalf of the GBS consortium   +46 more
doaj   +1 more source

Parvovirus B19 infection in pediatric transplant patients [PDF]

, 1993
Evidence of recent parvovirus virus infection (as determined by the presence of a positive IgM antibody titer) without other identified causes of anemia was found in 5 of 26 pediatric solid-organ transplant recipients evaluated for moderate-to-severe ...
Gartner, JC, Green, M, McLoughlin, L, Michaels, M, Nour, B, Reyes, J, Starzl, TE, Tzakis, A   +7 more
core   +1 more source

Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial

Pediatrics, 2019
Etanercept in a randomized clinical trial exhibited potential benefit as an adjunctive IVIg treatment of acute KD in select prespecified subgroups. BrightcoveDefaultPlayer10.1542/6138644048001PEDS-VA_2018-3675 Video Abstract OBJECTIVES: Patients with ...
M. Portman, N. Dahdah, A. Slee, A. Olson, N. Choueiter, B. Soriano, S. Buddhe, C. Altman   +7 more
semanticscholar   +1 more source